A detailed history of Dechtman Wealth Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Dechtman Wealth Management, LLC holds 3,992 shares of ABT stock, worth $456,006. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,992
Previous 3,977 0.38%
Holding current value
$456,006
Previous $413,000 10.17%
% of portfolio
0.09%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$100.07 - $118.13 $1,501 - $1,771
15 Added 0.38%
3,992 $455,000
Q2 2024

Jul 29, 2024

SELL
$100.73 - $112.44 $17,023 - $19,002
-169 Reduced 4.08%
3,977 $413,000
Q1 2024

Apr 23, 2024

BUY
$109.52 - $120.96 $2,190 - $2,419
20 Added 0.48%
4,146 $471,000
Q4 2023

Jan 19, 2024

SELL
$90.19 - $110.4 $5,591 - $6,844
-62 Reduced 1.48%
4,126 $454,000
Q3 2023

Oct 16, 2023

BUY
$95.53 - $114.62 $400,079 - $480,028
4,188 New
4,188 $406,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Dechtman Wealth Management, LLC Portfolio

Follow Dechtman Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dechtman Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dechtman Wealth Management, LLC with notifications on news.